1349770-61-1

Basic information

• Product Name: tert-butyl N-[[4-[5-[2-[bis(tert-butoxycarbonyl)amino]-5-(4-isopropylsulfonylphenyl)-3-pyridyl]-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-methyl-carbamate
• Synonyms: tert-butyl N-[[4-[5-[2-[bis(tert-butoxycarbonyl)amino]-5-(4-isopropylsulfonylphenyl)-3-pyridyl]-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-methyl-carbamate
• CAS NO: 1349770-61-1
• Molecular Weight: 763.912
• Mol File: 1349770-61-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: tert-butyl N-[[4-[5-[2-[bis(tert-butoxycarbonyl)amino]-5-(4-isopropylsulfonylphenyl)-3-pyridyl]-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-methyl-carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl N-[[4-[5-[2-[bis(tert-butoxycarbonyl)amino]-5-(4-isopropylsulfonylphenyl)-3-pyridyl]-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-methyl-carbamate(1349770-61-1)
• EPA Substance Registry System: tert-butyl N-[[4-[5-[2-[bis(tert-butoxycarbonyl)amino]-5-(4-isopropylsulfonylphenyl)-3-pyridyl]-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-methyl-carbamate(1349770-61-1)

Safety Data

• Hazardous Substances Data: 1349770-61-1(Hazardous Substances Data)

Upstream product

• 1232424-40-6 tert-butyl N-[[4-(hydrazinecarbonyl)phenyl]methyl]-N-methyl-carbamate 
• 1256359-13-3 2-(4-isopropylsulfonylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 1349770-59-7 tert-butyl N-[[4-[5-[2-[bis(tert-butoxycarbonyl)amino]-5-bromo-3-pyridyl]-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-methyl-carbamate 
• 1349770-57-5 tert-butyl N-[[4-[5-(2-amino-5-bromo-3-pyridyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-methyl-carbamate 
• 1349770-55-3 tert-butyl N-[[4-[[(2-amino-5-bromo-pyridine-3-carbonyl)amino]carbamoyl]phenyl]methyl]-N-methyl-carbamate 
• 52833-94-0 2-amino-5-bromonicotinicacid 

Downstream Products

• 1349770-42-8 5-(4-isopropylsulfonylphenyl)-3-[5-[4-(methylaminomethyl)phenyl]-1,3,4-oxadiazol-2-yl]pyridin-2-amine 

Relevant articles and documents

2 -AMINOPYRIDINE DERIVATIVES USEFUL AS INHIBITORS OF ATR KINASE

The present invention relates to pyridine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating various diseases, disord